Kaüna is a digital nephrology platform to optimize patient health, revenue, and operations. The company is on a mission to help independent nephrology practices & dialysis centers optimize patient health outcomes, maximize financial performance & operational efficiency, whilst maintaining a healthy & happy workforce.

Lab-to-Launch Lounge

Thursday, October 23, 2025

Dr. Collins Oghor earned his Doctor of Medicine, Master of Surgery, and MBA from McGill University before embarking on a MPH in Health Management from the Harvard T.H. Chan School of Public Health. He is the CEO of Kauna (formerly Collogh Cares Inc.) which he founded after losing a loved one to kidney disease. The company's flagship NephroAI platform uses artificial intelligence to predict when patients will need dialysis years in advance. The platform also provides care management services that support kidney specialist clinics. His work spans global health initiatives with UNOPS and McKinsey's Africa Delivery Hub. As a 2023-2024 Cheng Fellow at the Harvard Kennedy School he is dedicated to expanding access to healthcare in Nigeria.

One piece of advice to Venturing@Harvard

Entrepreneurship is something you have to be fully committed to as a way of life.